A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis

David Gibson; AJ Bjourson; Amanda Eakin; Philip Gardiner; Gary Wright; Naomi Todd

A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis

David Gibson (Inventor), AJ Bjourson (Inventor), Amanda Eakin (Inventor), Philip Gardiner (Inventor), Gary Wright (Inventor), Naomi Todd (Inventor)

Research output: Patent

Abstract

The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/el or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.

Original language	English
Patent number	US2023257815A1
IPC	C12Q1/6883
Priority date	25/06/20
Filing date	25/06/21
Publication status	Published online - 17 Aug 2023

Keywords

Rheumatoid Arthritis
DMARD
disease activity
Response prediction

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://worldwide.espacenet.com/patent/search/family/071949804/publication/US2023257815A1?q=pn%3DUS2023257815A1

Cite this

Gibson, D., Bjourson, AJ., Eakin, A., Gardiner, P., Wright, G., & Todd, N. (2023). A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis. (Patent No. US2023257815A1). Advance online publication. https://worldwide.espacenet.com/patent/search/family/071949804/publication/US2023257815A1?q=pn%3DUS2023257815A1

@misc{a81944f6205d46b0ba2aa83609b3c0c5,

title = "A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis",

abstract = "The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/el or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.",

keywords = "Rheumatoid Arthritis, DMARD, disease activity, Response prediction",

author = "David Gibson and AJ Bjourson and Amanda Eakin and Philip Gardiner and Gary Wright and Naomi Todd",

year = "2023",

month = aug,

day = "17",

language = "English",

type = "Patent",

note = "US2023257815A1; C12Q1/6883",

}

Gibson, D , Bjourson, AJ, Eakin, A, Gardiner, P, Wright, G & Todd, N Aug. 17 2023, A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis, Patent No. US2023257815A1. <https://worldwide.espacenet.com/patent/search/family/071949804/publication/US2023257815A1?q=pn%3DUS2023257815A1>

TY - PAT

T1 - A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis

AU - Gibson, David

AU - Bjourson, AJ

AU - Eakin, Amanda

AU - Gardiner, Philip

AU - Wright, Gary

AU - Todd, Naomi

PY - 2023/8/17

Y1 - 2023/8/17

N2 - The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/el or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.

AB - The present invention relates to a method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis by determining the quantitative level of one or more biomarkers and either predicting response to treatment with a disease-modifying anti-rheumatic drug, classifying disease activity, and/el or predicting response to treatment with a disease-modifying anti-rheumatic drug and classifying disease activity.

KW - Rheumatoid Arthritis

KW - DMARD

KW - disease activity

KW - Response prediction

M3 - Patent

M1 - US2023257815A1

Y2 - 2021/06/25

ER -

A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or classifying disease activity in a subject with rheumatoid arthritis

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this